finance Archives

Biotech By Allison DeAngelis

With cryptocurrency and NFTs, ‘decentralized science’ seeks to upend drug industry financing

a photo of the federal trade comission building

Hospitals By Bob Herman

HCA, Steward abandon hospital deal in another win for FTC

The Readout LOUD By Adam Feuerstein, Meg Tirrell and Damian Garde

A longtime investor talks interest rates, biotech, and why luxury cars are a warning sign

Biotech By Allison DeAngelis

Third Rock Ventures plots next chapter after raising $1.1 billion fund

OrigamiBoats_Illustration_MollyFerguson_051822

A STAT Investigation By Casey Ross

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

Biotech By Allison DeAngelis

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

BiotechClawMachine_Illustration_MollyFerguson_051122

Biotech By Kate Sheridan

When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

Business By Bob Herman

Real estate firms own nearly 1 in 10 health care properties

Insurance By Bob Herman

Seven health insurance CEOs raked in a record $283 million last year

Hospitals By Tara Bannow

Advocate Aurora-Atrium’s mammoth merger: Experts split on whether federal regulators will challenge the deal

First Opinion Podcast By Patrick Skerrett

Listen: Get sick, go to the doctor, incur debt, repeat

Biotech By Allison DeAngelis

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

Business By Tara Bannow and Bob Herman

Omicron squeezed hospitals more than health insurers in the first quarter

Biotech By Adam Feuerstein and Damian Garde

Biogen board slashes CEO’s bonus as Aduhelm sales and overall business struggle

First Opinion By Michelle Proser

How hospitals and health systems can help patients avoid medical debt

Hospitals By Tara Bannow

Travel nurses remain pricey, and it’s weighing on hospital profits

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices

First Opinion By Alyssa Jaffee

If there is a digital health bubble, does it really matter for entrepreneurs?

Health Tech By Mohana Ravindranath and Mario Aguilar

Health tech companies strike deals to grow virtual diabetes care, telepsychiatry

D.C. Diagnosis By Nicholas Florko

The next battle in the never-ending war over Aduhelm

Insurance By Bob Herman

Omicron’s speedy retreat helped bolster UnitedHealth Group’s bottom line

Insurance By Bob Herman

‘Completely unsustainable’: Small employers brace for giant health insurance price hikes

Special Report By Tara Bannow

Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines

Opinions+ By Marc Herant and Jason Brauner

Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D

Biotech By Kate Sheridan

Most Read

Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds

New Jersey hospitals scrap merger after FTC challenge

Health tech companies are facing a wave of layoffs

Biospring Partners closes $245 million first fund as private markets tense up

Study suggests a new harm from hospital mergers: less price transparency

Carbon Health, citing concerns about path to profitability, lays off 250 employees

More and more biotechs are worth less than their checking accounts

Proton cancer centers continue to proliferate, despite shaky benefits and checkered financiers

All Coverage

With cryptocurrency and NFTs, ‘decentralized science’ seeks to upend drug industry financing

HCA, Steward abandon hospital deal in another win for FTC

A longtime investor talks interest rates, biotech, and why luxury cars are a warning sign

Third Rock Ventures plots next chapter after raising $1.1 billion fund

How a complex web of businesses turned private health records from GE into a lucrative portrait of patients

Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences

When biotech acquisitions spike, early-stage startups are prime targets, analysis shows

Real estate firms own nearly 1 in 10 health care properties

Seven health insurance CEOs raked in a record $283 million last year

Advocate Aurora-Atrium’s mammoth merger: Experts split on whether federal regulators will challenge the deal

Listen: Get sick, go to the doctor, incur debt, repeat

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

Omicron squeezed hospitals more than health insurers in the first quarter

Biogen board slashes CEO’s bonus as Aduhelm sales and overall business struggle

How hospitals and health systems can help patients avoid medical debt

Travel nurses remain pricey, and it’s weighing on hospital profits

Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices

If there is a digital health bubble, does it really matter for entrepreneurs?

Health tech companies strike deals to grow virtual diabetes care, telepsychiatry

The next battle in the never-ending war over Aduhelm

Omicron’s speedy retreat helped bolster UnitedHealth Group’s bottom line

‘Completely unsustainable’: Small employers brace for giant health insurance price hikes

Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines

Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D

Private equity giant Carlyle to acquire biotech venture capital firm Abingworth

Subscribe to STAT for $15 per month lorem ipsum